Lido Advisors, LLC Eli Lilly & CO Transaction History

Lido Advisors, LLC

$20.3 Billion
Q3 2024

A detailed history of Lido Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lido Advisors, LLC holds 49,224 shares of LLY stock, worth $38.7 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

49,224

Previous 56,531 12.93%

Holding current value

$38.7 Million

Previous $51.2 Million 14.8%

% of portfolio

0.21%

Previous 0.29%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $5.64 Million - $7.01 Million	-7,307 Reduced 12.93%	49,224 $43.6 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $12 Million - $15 Million	16,502 Added 41.23%	56,531 $51.2 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $1.12 Million - $1.5 Million	1,895 Added 4.97%	40,029 $31.1 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $568,780 - $670,517	1,083 Added 2.92%	38,134 $22.2 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $1.35 Million - $1.86 Million	3,098 Added 9.12%	37,051 $19.9 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $710,949 - $950,622	-2,027 Reduced 5.63%	33,953 $15.9 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $2.15 Million - $2.52 Million	-6,910 Reduced 16.11%	35,980 $12.4 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $883,940 - $1.03 Million	2,749 Added 6.85%	42,890 $15.7 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $2.98 Million - $3.4 Million	10,066 Added 33.47%	40,141 $13 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $1.19 Million - $1.4 Million	-4,278 Reduced 12.45%	30,075 $9.75 Million
Q1 2022 May 17, 2022	BUY	$234.69 - $291.66 $1.06 Million - $1.31 Million	4,500 Added 15.07%	34,353 $9.84 Million
Q4 2021 Feb 15, 2022	SELL	$224.85 - $279.04 $866,571 - $1.08 Million	-3,854 Reduced 11.43%	29,853 $8.22 Million
Q3 2021 Feb 15, 2022	BUY	$221.6 - $272.71 $116,340 - $143,172	525 Added 1.58%	33,707 $7.79 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $3.09 Million - $3.8 Million	13,925 Added 72.31%	33,182 $7.66 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $450,111 - $582,215	2,493 Added 14.87%	19,257 $4.42 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $719,392 - $931,288	4,378 Added 35.35%	16,764 $3.13 Million
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $473,961 - $627,164	3,633 Added 41.51%	12,386 $2.09 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $514,109 - $594,661	-3,516 Reduced 28.66%	8,753 $1.3 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $109,272 - $131,508	801 Added 6.98%	12,269 $2.01 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $6,071 - $7,514	51 Added 0.45%	11,468 $1.59 Million
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $787,786 - $975,744	7,368 Added 181.97%	11,417 $1.5 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $84,684 - $92,114	-793 Reduced 16.38%	4,049 $453,000
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $210,168 - $245,320	1,897 Added 64.41%	4,842 $536,000
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $16,696 - $19,653	150 Added 5.37%	2,945 $382,000
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $52,738 - $59,082	-498 Reduced 15.12%	2,795 $323,000
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $39,238 - $49,040	457 Added 16.11%	3,293 $353,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $214,685 - $246,391	2,836 New	2,836 $242,000
Q3 2016 Sep 21, 2017	SELL	N/A	-4,483 Closed	0 $0
Q2 2016 Sep 18, 2017	SELL	N/A	-268 Reduced 5.64%	4,483 $353,000
Q1 2016 Sep 18, 2017	BUY	N/A	4,751	4,751 $342,000

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.

Account

Lido Advisors, LLC Eli Lilly & CO Transaction History